KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Restructuring Costs: 2014-2015

Historic Restructuring Costs for Aurinia Pharmaceuticals (AUPH) over the last 2 years, with Sep 2015 value amounting to $155,000.

  • Aurinia Pharmaceuticals' Restructuring Costs rose 158.33% to $155,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $192,000, marking a year-over-year change of. This contributed to the annual value of -$116,000 for FY2016, which is 25.16% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Restructuring Costs of $155,000 as of Q3 2015, which was up 507.89% from -$38,000 recorded in Q2 2015.
  • Aurinia Pharmaceuticals' 5-year Restructuring Costs high stood at $569,000 for Q1 2014, and its period low was -$38,000 during Q2 2015.
  • Its 2-year average for Restructuring Costs is $174,857, with a median of $60,000 in 2014.
  • Examining YoY changes over the last 5 years, Aurinia Pharmaceuticals' Restructuring Costs showed a top increase of 158.33% in 2015 and a maximum decrease of 109.43% in 2015.
  • Over the past 2 years, Aurinia Pharmaceuticals' Restructuring Costs (Quarterly) stood at $36,000 in 2014, then soared by 158.33% to $155,000 in 2015.
  • Its Restructuring Costs stands at $155,000 for Q3 2015, versus -$38,000 for Q2 2015 and $39,000 for Q1 2015.